The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.<\/p>\n
1435 GMT \u2013 Fresenius SE\u2019s third-quarter results continue its robust 2025 run, Citi analysts write in a note, after the German healthcare group reported higher revenue and earnings for the quarter. \u201cWe are encouraged by the strong operational performance across both Kabi and Helios,\u201d the analysts say, referring to Fresenius\u2019s pharmaceutical and hospital business units. Citi has a buy rating and a 52 euro target on the stock. Shares trade flat at 48.52 euros. (william.gray@wsj.com<\/a>)<\/p>\n Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…\n","protected":false},"author":2,"featured_media":161646,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[95433,95431,85833,41573,41570,13782,41565,6738,18,41571,14480,3334,135,475,474,82485,82483,19,41586,17,3544,95432,82482,2900,9436,44285,17917,26243,41580],"class_list":{"0":"post-165751","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-analysts-comments","9":"tag-analysts-comments-recommendations","10":"tag-ce-exclusion-filter","11":"tag-ce-industry-news-filter","12":"tag-content-types","13":"tag-corporate","14":"tag-corporate-industrial-news","15":"tag-earnings","16":"tag-eire","17":"tag-factiva-filters","18":"tag-financial-performance","19":"tag-general-news","20":"tag-health","21":"tag-health-care","22":"tag-healthcare","23":"tag-healthcare-provision","24":"tag-healthcare-life-sciences","25":"tag-ie","26":"tag-industrial-news","27":"tag-ireland","28":"tag-life-sciences","29":"tag-linkendrnrealtime-linkedarticle-dnco20251105016361","30":"tag-newsplus","31":"tag-pharmaceuticals","32":"tag-political","33":"tag-political-general-news","34":"tag-recommendations","35":"tag-synd","36":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/165751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=165751"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/165751\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/161646"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=165751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=165751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=165751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}